NewEdge Wealth’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
99,367
+22,233
+29% +$509K 0.02% 424
2026
Q1
$1.8M Buy
77,134
+26,732
+53% +$576K 0.02% 462
2025
Q4
$1.01M Buy
50,402
+4,580
+10% +$89.4K 0.01% 630
2025
Q3
$835K Buy
45,822
+8,472
+23% +$165K 0.01% 605
2025
Q2
$689K Buy
37,350
+5,392
+17% +$104K 0.01% 619
2025
Q1
$579K Buy
31,958
+5,845
+22% +$105K 0.01% 610
2024
Q4
$453K Buy
+26,113
New +$501K 0.01% 666

Other funds holding INVA

NewEdge Wealth's INVA Position: Q2 2026 in Review

NewEdge Wealth increased its Innoviva (INVA) stake by 29% in Q2 2026, buying an estimated $509K and bringing the position to 99,367 shares worth $2.26M. The position accounts for 0.02% of the portfolio, ranked #424.

NewEdge Wealth first reported a position in INVA in Q4 2024 and has held it in 7 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • NewEdge Wealth held 99,367 shares of Innoviva worth $2.26M as of Q2 2026.
  • NewEdge Wealth bought 22,233 Innoviva shares in Q2 2026, an estimated $509K.
  • Innoviva made up 0.02% of NewEdge Wealth's portfolio in Q2 2026, its #424 holding.
  • NewEdge Wealth first reported a position in Innoviva in Q4 2024 and has held it in 7 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.